Pre-formulation is a key step in the drug development process and consists of salt selection and polymorph studies. Currently a time consuming and expensive process, there is a tremendous need to expedite these studies. Symyx Technologies has recently developed a high throughput workflow that allows both salt selection and polymorph studies to be executed in a fraction of the time using much smaller amounts of material than conventional studies. One of the major components of the integrated hardware and software system that is currently being manufactured for sale as the Symyx Polymorph Discovery ToolTM, is a parallel Crystallization StationTM. Capable of performing cooling, evaporation, and precipitation crystallizations in a fully automated manner, this crystallization station has several unique design features that allow for the hot filtration and daughtering of saturated solutions and the isolation crystals on a Universal SubstrateTM. Crystalline samples isolated in this format, are analyzed using rapid serial birefringence, Raman, XRD, and parallel melting point measurements. Using a fully functional prototype and working in collaboration with several of the leading pharmaceutical companies in the U.S., we have performed over 10,000 crystallizations of pharmaceutically active compounds in three months. Currently performing 300 crystallizations per day this system makes it possible to complete typical salt selection or polymorph studies in as little as two to three weeks.
